BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32930408)

  • 1. Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement.
    Eke AC; Olagunju A; Momper J; Penazzato M; Abrams EJ; Best BM; Capparelli EV; Bekker A; Belew Y; Kiser JJ; Struble K; Taylor G; Waitt C; Mirochnick M; Cressey TR; Colbers A;
    Clin Pharmacol Ther; 2021 Jul; 110(1):36-48. PubMed ID: 32930408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV.
    Hodel EM; Marzolini C; Waitt C; Rakhmanina N
    Curr Pharm Des; 2019; 25(5):556-576. PubMed ID: 30894103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions.
    Angelidou K; Fowler MG; Flynn P; Coletti A; McCarthy K; Browning R; McIntyre J; Brummel SS; Shapiro DE; Tierney C;
    Clin Trials; 2020 Aug; 17(4):437-447. PubMed ID: 32191142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to accelerating the study of new antiretrovirals in pregnancy.
    Abrams EJ; Calmy A; Fairlie L; Mahaka IC; Chimula L; Flynn PM; Kinuthia J; Myer L; Khoo SH; Musoke P; Zwerski S; Zech JM; Lockman S; Siberry GK
    J Int AIDS Soc; 2022 Jul; 25 Suppl 2(Suppl 2):e25916. PubMed ID: 35851757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
    Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
    Sante; 1997; 7(2):115-25. PubMed ID: 9273118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of interventions to improve uptake and retention of HIV-infected pregnant and breastfeeding women and their infants in prevention of mother-to-child transmission care programs in low- and middle-income countries: protocol for a systematic review and meta-analysis.
    Puchalski Ritchie LM; van Lettow M; Hosseinipour MC; Rosenberg NE; Phiri S; Landes M; Cataldo F; Straus SE;
    Syst Rev; 2015 Nov; 4():144. PubMed ID: 26525141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.
    Clarke DF; Penazzato M; Capparelli E; Cressey TR; Siberry G; Sugandhi N; Mirochnick M;
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):83-93. PubMed ID: 29039686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral drugs to prevent mother-to-child transmission of HIV during breastfeeding.
    Shetty AK; Maldonado Y
    Curr HIV Res; 2013 Mar; 11(2):102-25. PubMed ID: 23432487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action.
    Penazzato M; Lockman S; Colbers A; Renaud F; Calmy A; Clayden P; Vicari M; Mahaka IC; Zech JM; Irvine C; Abrams EJ;
    J Int AIDS Soc; 2022 Jul; 25 Suppl 2(Suppl 2):e25912. PubMed ID: 35851834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic optimization of antiretroviral therapy in pregnancy.
    Buckoreelall K; Cressey TR; King JR
    Clin Pharmacokinet; 2012 Oct; 51(10):639-59. PubMed ID: 23018528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral drugs to prevent breastfeeding HIV transmission.
    Mofenson LM
    Antivir Ther; 2010; 15(4):537-53. PubMed ID: 20587847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries.
    McIntyre J
    Curr Opin HIV AIDS; 2010 Jan; 5(1):48-53. PubMed ID: 20046147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral interventions for preventing breast milk transmission of HIV.
    White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries.
    Kieffer MP; Mattingly M; Giphart A; van de Ven R; Chouraya C; Walakira M; Boon A; Mikusova S; Simonds RJ;
    J Acquir Immune Defic Syndr; 2014 Dec; 67 Suppl 4(Suppl 4):S188-94. PubMed ID: 25436817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.